[Federal Register Volume 65, Number 14 (Friday, January 21, 2000)]
[Notices]
[Pages 3504-3505]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-1474]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION


Issuer Delisting; Notice of Application to Withdraw From Listing 
and Registration; (Enzo Biochem, Inc., Common Stock, Par Value $.01 per 
Share) File No. 1-9974

January 13, 2000.
    Enzo Biochem, Inc. (``Company''), has filed an appliction with the 
Securities and Exchange Commission (``Commission''), pursuant to 
Section 12(d) of the Securities Exchange Act of 1934 (``Act'') \1\ and 
Rule 12d2-2(d) thereunder,\2\ to withdraw the security specified above 
(``Security'') from listing and registration on the American Stock 
Exchange LLC (``Amex'' or ``Exchange'').
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78l(d).
    \2\ 17 CFR 240.12d2-2(d).
---------------------------------------------------------------------------

    The Security has been listed for trading on the Amex and, pursuant 
to a Registration Statement on Form 8-A filed with the Commission which 
became effective on December 8, 1999, on the New York Stock Exchange, 
Inc. (``NYSE''). Trading in the Security on the NYSE commenced at the 
opening of business on December 16, 1999.
    The Company has complied with Amex Rule 18 by filing with the 
Exchange a certified copy of the preambles and resolutions adopted by 
the Company's Board of Directors authorizing the withdrawal of its 
Security from listing and registration on the Exchange and by setting 
forth in detail to the Exchange the reasons for such proposed 
withdrawal and the facts in support thereof. The Amex has in turn 
informed the Company that it does not object to the proposed withdrawal 
of the Company's Security from listing and registration on the 
Exchange.
    In making the decision to withdraw the Security from listing on the 
Amex in conjunction with its new listing on the NYSE, the Company has 
cited its desire to avoid the direct and indirect costs, as well as the 
division of the market for its Security, which would arise from 
maintaining simultaneous listings on the Amex and the NYSE. The Company 
believes that the NYSE listing will provide better marketplace 
visibility for its Security than the Amex did and thereby enhance its 
value for shareholders.

[[Page 3505]]

    The Company's application relates solely to the withdrawal of the 
Security from listing and registration on the Amex and shall have no 
effect upon the Security's continued listed and registration on the 
NYSE. By reason of Section 12(b) of the Act \3\ and the rules and 
regulations of the Commission thereunder, the Company shall continue to 
be obligated to file reports with the Commission under Section 13 of 
the Act.\4\
---------------------------------------------------------------------------

    \3\ 15 U.S.C. 78l(b).
    \4\ 15 U.S.C. 78m.
---------------------------------------------------------------------------

    Any interested person may, on or before February 4, 2000, submit by 
letter to the Secretary of the Securities and Exchange Commission, 450 
Fifth Street, N.W., Washington, D.C. 20549-0609, facts bearing upon 
whether the application has been made in accordance with the rules of 
the Exchange and what terms, if any, should be imposed by the 
Commission for the protection of investors. The Commission, based on 
the information submitted to it, will issue an order granting the 
application after the date mentioned above, unless the Commission 
determines to order a hearing on the matter.
    For the Commission, by the Division of Market Regulation, pursuant 
to delegated authority.\5\
---------------------------------------------------------------------------

    \5\ 17 CFR 200.30-3(a)(1).

Jonathan G. Katz,
Secretary.
[FR Doc. 00-1474 Filed 1-20-00 8:45 am]
BILLING CODE 8010-01-M